Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings

ABEO·Reported May 13, 2026·Before market open

Abeona Therapeutics Inc. reported Q1 2026 revenue of $8.7M, beat analyst consensus of $4.6M by $4.1M. Diluted EPS came in at $-0.30 (-25.0% YoY), beat the $-0.33 consensus by $0.03.

Revenue
$8.7Mbeat by $4.1M
Consensus: $4.6M
Diluted EPS
$-0.30beat by $0.03
Consensus: $-0.33
SEC

SEC Filings

Earnings release8-K · 0001493152-26-022610
Quarterly report10-Q · 0001493152-26-022614

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Abeona Therapeutics Inc.'s Q1 2026 earnings report.

Abeona Therapeutics Inc. (ABEO) reported Q1 2026 earnings on May 13, 2026 before market open.

Abeona Therapeutics Inc. reported revenue of $8.7M and diluted EPS of $-0.30 for Q1 2026.

Revenue beat the consensus estimate of $4.6M by $4.1M. EPS beat the consensus estimate of $-0.33 by $0.03.

Compared to the same quarter a year prior, diluted EPS declined 25.0% from $-0.24.

You can read the 8-K earnings release (0001493152-26-022610) and the 10-Q periodic report (0001493152-26-022614) directly on SEC EDGAR. The filing index links above go to sec.gov.